NFKB2 Gene
Introduction <table class="infobox infobox-gene">Gene Symbol </td>Full Name </td>Chromosomal Location </td>NCBI Gene ID </td>Ensembl ID </td>UniProt ID </td>Aliases </td>
Nfkb2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...
NFKB2 Gene
Introduction <table class="infobox infobox-gene">Gene Symbol </td>Full Name </td>Chromosomal Location </td>NCBI Gene ID </td>Ensembl ID </td>UniProt ID </td>Aliases </td>
Nfkb2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
NFKB2 encodes the p100 (NFKB2) protein, which is a member of the [NF-kappaB](/entities/nf-kb) transcription factor family. Unlike other NF-kappaB proteins, NFKB2 is synthesized as a full-length p100 that functions as both an inhibitor and a transcription factor. The p100 precursor can be proteolytically processed to generate the active p52 subunit, which translocates to the nucleus. NFKB2 is crucial for immune function, inflammation, and cell survival. Germline mutations in NFKB2 cause immunodeficiency and endocrine disorders [@nfb2008][@nfb2012].
Gene Structure NFKB2 spans ~15 kb:
Exons : 24 coding exonsTranscript : ~2.8 kb mRNAProtein : 900 amino acids, ~100 kDa (p100); 52 kDa (p52)Normal Function
Alternative NF-κB Pathway NFKB2 regulates:
Non-canonical pathway — Specific NF-κB signalingB cell function — Maturation and survivalLymphoid organogenesis — Secondary lymphoid structuresAdaptive immunity — T cell dependent responsesProcessing p100 to p52:
Constitutive processing — Basal levelsInducible processing — Via NIK kinaseSignal-specific — Lymphoid receptor signalingDimer formation — With RelB for active complexTarget Genes NFKB2 regulates:
Immune genes — Cytokines, chemokinesSurvival genes — Bcl-2 familyDifferentiation — Cell fate genes [@microglial2015]Role in Neurodegeneration
Alzheimer's Disease NFKB2 in AD:
Neuroinflammation — Elevated p100/p52 in AD[Aβ](/proteins/amyloid-beta) response — Activated by amyloidNeuronal dysfunction — Altered NF-κB regulationParkinson's Disease
Neuroinflammation — p52 pathway activated in PDDopaminergic [neurons](/entities/neurons) — May affect survivalStroke
Ischemic injury — p100 processing after strokeKey Publications
PMID: 8340146 (https://pubmed.ncbi.nlm.nih.gov/8340146/) — Discovery of NFKB2PMID: 10625657 (https://pubmed.ncbi.nlm.nih.gov/10625657/) — NFKB2 structurePMID: 11025718 (https://pubmed.ncbi.nlm.nih.gov/11025718/) — Non-canonical NF-κBPMID: 21479819 (https://pubmed.ncbi.nlm.nih.gov/21479819/) — NFKB2 in neurodegeneration
See Also
[NFKB2 Protein](/proteins/nfkb2-protein)
[NF-κB Signaling](/mechanisms/nf-kappa-b-signaling)
[Alzheimer's Disease](/diseases/alzheimers-disease)
Background The study of Nfkb2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Expression Pattern
Tissue Distribution NFKB2 exhibits tissue-specific expression:
[Immune system *: High expression in spleen, thymus, lymph nodes](/genes/th)
[Brain *: Detected in neur](/mechanisms/cte)ons, astrocytes, and [microglia](/cell-types/microglia-neuroinflammation)
Peripheral tissues : Moderate expression in lung, liver, kidneyCell lines : Various leukemia and lymphoma cell linesCellular Expression In the brain:
Neurons : Constitutive expression in cortical and hippocampal neurons[Astrocytes](/entities/astrocytes) : Upregulated during neuroinflammation[Microglia](/entities/microglia) : Strong activation-dependent expressionOligodendrocytes : Lower baseline expressionAnimal Models
Knockout Studies Nfkb2 knockout mice have provided insights:
Defective lymphoid organogenesis : Impaired lymph node developmentB cell abnormalities : Reduced B cell numbers and functionHumoral immunity defects : Poor antibody responsesPartial lethality : Some embryonic lethality in null miceTransgenic Models
Constitutive activation : p52 overexpression modelsBrain-specific : Neuronal NFKB2 deletion studiesDisease models : Crossed with [APP](/entities/app-protein)/PSEN1 for AD studiesInteracting Proteins
Direct Interactions NFKB2 interacts with several proteins:
RELB : Forms active p52/RELB heterodimerNFKB1 (p105) : Can form heterodimersIKBKB : Phosphorylation targetNIK (MAP3K14) : Key kinase for processingBCL3 : Co-activator proteinSignaling Complexes
Canonical与非canonical交叉 : p100 can inhibit canonical NF-κBProcessing machinery : Proteasome-dependent degradationNuclear import : Through nuclear localization signalsClinical Significance
Germline Mutations NFKB2 mutations cause:
Immunodeficiency : Combined immunodeficiencyEndocrine disorders : ACTH deficiencyAlopecia : Hair loss in some patientsAutoimmunity : Lupus-like featuresSomatic Alterations
Lymphomas : Mutations in B cell malignanciesSolid tumors : Altered in some carcinomasAutoimmune disease : Association with autoimmune disordersPharmacology
Therapeutic Targets Drugs targeting NFKB2 pathway:
NIK inhibitors : Under development for cancerProteasome inhibitors : Bortezomib affects p52 processingBroad NF-κB inhibitors : Affects multiple pathwaysBiomarker Potential NFKB2 as a biomarker:
Disease activity : Levels correlate with inflammationTreatment response : Changes with therapyPrognostic value : In some malignanciesReferences
[Unknown, NF-κB in Alzheimer's disease (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18675312/)
[Unknown, NF-κB and neuroinflammation in PD (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22446967/)
[Unknown, Microglial NF-κB activation in neurodegeneration (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/260/)
[Unknown, Therapeutic targeting of NF-κB in AD (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31210156/)
[Unknown, α-synuclein and NF-κB activation (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24733664/)
[Unknown, NFKB2 in immune regulation (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28315656/)
Pathway Diagram The following diagram shows the key molecular relationships involving NFKB2 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description